NanoSURE (NSF-REU) at UNC Charlotte
NanoSURE (NSF-REU) at UNC Charlotte
National Science Foundation (NSF) Research Experience for Undergraduates (REU)
  • Home
  • Research Projects for 2025
  • Online Application
  • Follow-up for past participants
  • About UNC Charlotte

Contact Us

Prof. Michael G. Walter
REU Program Director
Department of Chemistry
UNC Charlotte
9201 University City Boulevard
Charlotte, NC 28223

704-687-8291
Michael.Walter@uncc.edu

Project Descriptions

  • Project 1 – Structure and Function of Copper Proteins
  • Project 2 – Fluorescent Sensors for Photoinduced Electron Transfer
  • Project 3 – Light-Activated Multifunctional Silica-Based Nanoparticles for Therapeutic Applications
  • Project 4 – Light Effect Transistors (LETs) in Photonic Integrated Circuits
  • Project 5 – Computational design of materials for harnessing heat as a renewable energy resource
  • Project 6 – Silicon pincer complexes for organic electronic applications
  • Project 7 – Synthesis, Growth Mechanism Study, and Property Measurement of Metalloid Tellurium Nanostructures
  • Project 8 – Dynamic Assembly of Electroactive Organometallic Polymers
  • Project 9 – Dynamic RNA Nanoparticles and Reconfigurable Nanoassemblies with Controllable Immunological Properties
  • Project 10 – Reconfigurable RNA-based Supra-assemblies

Links

  • Dept of Chemistry
  • UNC Charlotte
National Science Foundation logo

Funding provided by NSF-REU program through NSF Award DMR-2150172

Project 3 – Light-Activated Multifunctional Silica-Based Nanoparticles for Therapeutic Applications

December 02, 2022 by Tom Schmedake
Categories: Updates

The purpose of this project is to develop novel multifunctional silica-based hybrid nanoparticles with outstanding properties for photodynamic therapy (PDT) and photodynamic inactivation (PDI) applications.

Research Mentor

Juan Vivero-Escoto (Chemistry)

Description

Photodynamic therapy (PDT) is a light-based therapy that avoids most of the side effects of traditional chemical and radiation therapies. The principle of PDT is based on the selective internalization of a photosensitizer which upon irradiation with light generates reactive oxygen species that kill cancer cells. This approach can be expanded to eliminate antibiotic resistant bacteria, it is known as photodynamic inactivation (PDI). Traditionally, porphyrin-based photosensitizers have dominated the field; however, recent developments have shown that novel photosensitizing agents such as chlorin and phthalocyanine molecules are an excellent alternative. Nevertheless, these compounds still have similar disadvantages as porphyrin molecules such as low water solubility and reduced selectivity for targeted cancer cells. Nanoparticles represent emerging drug delivery systems that can overcome most of these issues. In this project, we will synthesize novel silica-based platforms including mesoporous silica nanoparticles (MSNs), polysilsesquioxane (PSilQ) and polyhedral oligomeric silsesquioxane (POSS) nanomaterials for the improved delivery of photosensitizing agents. The therapeutic properties of the silica-based hybrid nanoparticles will be tested in vitro using cancer cells and/or antibiotic resistant bacteria.

D

REU Students’ Role

The students in Dr. Vivero-Escoto’s lab will be involved with the synthesis and characterization of photosensitizing agents and nanoparticles. Synthetic methods such as reverse microemulsion and sol-gel will be used to produce nanoparticles. These materials will be characterized by a wide variety of techniques such as dynamic light scattering, thermogravimetric analysis, surface analyzer, and scanning and transmission electron microscopy. The students will also be exposed to the in vitro experiments to determine the therapeutic effect against cancer cell lines and/or antibiotic resistant bacteria.

Skip to toolbar
  • Log In